Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 16, 1999 - Issue 6
Submit an article Journal homepage
13
Views
8
CrossRef citations to date
0
Altmetric
Research Article

PERIPHERAL NEUROPATHY DURING ALPHA-INTERFERON THERAPY IN A CHILD WITH HODGKIN'S DISEASE

Suna Emir Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Tezer Kutluk Bone Marrow Transplantation Section, Department of Pediatrics, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
,
Ka Wah Chan Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Bilgehan Yalcin Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Kubilay Varli Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey
&
Munevver Buyukpamukcu Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
Pages 557-560 | Published online: 09 Jul 2009

References

  • Fattovich G, Giustina G, Favarato S, et al. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alpha interferon. J Hepato/. 1996;24:38–47.
  • Negoro K, Fukusako T, Morimatsu M, et al. Acute axonal polyneuropathy during interferon a-2A therapy for chronic hepatitis type C. Muscle Nerve. 1994;17:1351–1352.
  • Rutkove SB. An unusual axonal polyneuropathy induced by low-dose interferon alpha-2a. Arch Neurol 1997;54:907–908.
  • Bernsen PLJA, Wong-Chung RE, Janssen JTP. Neuralgic amyo trophy and polyradiculopathy during interferon therapy. Lancet. 1985;5:50.
  • Tambini R, Quattrini A, Frac assetti 0, et al. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumato/. 1997;24:1656–1658.
  • Smedley H, Katrak M, Sikora K, et al. Neurological effects of recombinant human interferon. BMJ 1983;286:262–264.
  • Klingemann HS, Grigg AP, Wilkie-Boyd K, et al. Treatment with recombinant interferon (a 2b) early after bone marrow transplantation in patients at high risk for relapse. Blood. 1991;78: 3306–3311.
  • Mazza P, Tura S, Bocchia M, et al. Alpha-2b recombinant interferon (Intro n) in Hodgkin's lymphoma. Eur J Haematol. 1990;52:22–24.
  • Rybak ME, Mc Carroll K, Bernard S, et al. Interferon therapy of relapsed and refractory Hodgkin's disease. J Biol Response Mod. 1990;9:1–4.
  • Csongor K Interferons in pediatric oncology end of the beginning or beginning of the end? Med Pediatr Oncol. 1998;30:364-366.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.